President Trump, Mass, Vaccine Manufacturing discussed on Science Friday

Automatic TRANSCRIPT

We want to be able to be resilient to them. So I do think that we have to fix that window of opportunity right now to fix this. To get pandemic preparedness, the attention it deserves, so that it is sustainable so that it is funded more the way the Department of Defense funds budgets. If you think about how much money we spend on pandemic preparedness, compared to how much we spend on another 35 fighter plane. You can't even compare the two and look what Look what's happened with this pandemic. It's been said that if you stop this pandemic a month earlier will save half a trillion dollars. Let's talk about preparing for it because there's a lot of talk of using the Defense Production act to help ramp up production of vaccines Image. Tell us what the actors can the government start directing companies to produce Vaccines. How does this work? So the defense production It has lots of different sections to it in lots of different aspects to it, And I'm not a lawyer, So I'm going to give you my understanding of how it applies in an infectious disease emergency. What it does is, it allows the president to To have cos prioritized orders from the U. S government say that might be a vaccine and might be syringes. It might be some ingredient that's needed in masks, for example, and it allows things to happen much quicker. Those contracts get prioritized. Some of the red tape disappears, and it just gives a lot of power to the president. T direct. Resource is towards what is deemed a national security emergency and it's been invoked before but by President Trump, and it's been invoked for other things in the past as well. But what I don't think what I think we have to think about is that it's not going to be a magic bullet and the fact that we're actually getting to the DP A for masks, For example, this far into the pandemic tells you that there's been a lot of failures that the DPH needs to be put into place, because, remember the After 2000 and h one n one. The strategic national stockpile was not repeated event 95, Mass. We have no one to blame for the fact that we need to deep now but ourselves. Thomas. We're relying then on private companies to create these vaccines that don't give up their trade secrets very easily. Is that an issue? Yeah, so I wanted to build on a couple of things to me, I said, and then answer that question. So one thing they're appreciate it is not only did H one n one shift people's expectations of what a pandemic might look like at this country. We had done all this investment after 9 11, particularly between 4 4007, and we were hit by the financial crisis, and that's really where you saw states and localities and to some extent the federal government start to cut funding. To that preparedness programs because the easiest thing to do, of course, is always to cut for capacity that you hope you'll never need to use and each one and one reinforce that impulse but is really the combination. Of those two things that hurt us in the past Esso in terms of the DP A. It certainly creates a Potential vehicle two for the president to provide economic incentives to try to mobilize domestic industrial capabilities to meet a national security crisis like this one In terms of vaccines. So far, we we actually haven't had as much of a challenge in terms of mobilizing that supply and having companies provided certainly nine person to some other nations. Even the European Union is having some struggles getting their vaccines on time, but it's definitely something the background that can be used if needed to move for those supplies. The problem really has been in terms of mobilizing the capacity more so in some other areas like Hamish mentioned around P p p to be a year into this crisis. And to not have solved that challenges. Really, uh, disappointing, to say the least, and obviously has had a tremendous health costs, particularly at a time where we may need better. Mass, particularly given more contagious, very instead are starting to circulate. Are you saying that the mobilization of the Defense Act will not put more people on the ground as they like to say in the military boots on the ground to be able to distribute the vaccine to get it into maybe planes that need to fly to certain places to have soldiers who were qualified to be able to dispense it. I've already seen soldiers on the ground and In parking lots giving out the injections. Are you saying that won't help that? Deepa is more around production and supplied the actual vaccines. We are seeing mobilization of vaccinators. So through FEMA, you're seeing a ramp up of the availability of vaccinators and starting to reach out. To broader populations and provide the training. You would need to have them be vaccinators. I think the big issue on vaccine capacity and manufacturing is are we going to be able to commence country our company's rather that have failed candidates. To provide their manufacturing capacity to the successful candidates, and we're starting to see that so no fee announced. I think it was last week that they would be manufacturing the Fizer vaccine, Merc recently announced that its candidate failed That's another source of potential manufacturing capacity. That you could bring to bear. But what people under need to understand is as exciting as the stories were in the early days of this pandemic of machinist and companies said had never built a ventilator, trying to build one on the fly, mobilizing new companies to make anything from toilet paper to pee pee. That's harder to do in the vaccine manufacturing contest context. Vaccine Manufacturing is one of the most complex manufacturing challenges in the world is part of the reason why so few countries can actually do it. The fastest way to increase our supplies to get existing manufacturers, particularly those that don't have a successful candidate. Tonto manufacture the successful products and we're starting to see that I have Hope that we'll see more of that moving forward. I'm Ira Plato. And this is Science Friday from W. N. Y C studios. The national plan talks about mass vaccination campaigns turning stadiums into places where you can vaccinate Hundreds in a day. Do you actually see that happening? And is that the right way to go? It is one of its a component of the right way to go, and it's certainly what we advocate for in that New York Times piece. If we're going to hit the targets that we need to hit to sustain One million vaccinations per day for 100 days and I should point out here we we all have seen a ramp up of vaccinations in the US over the last week and a half. We're still averaging since December 14th when the rollout began. We're still averaging just a little over 500,000 per day. So sustaining this for 100 days, even at one million a day would be a feat. The president has said. You want to reach 1.5 million a day to hit these targets. You need a component. That involves mass vaccination ideally of a population where their eligibility for vaccination because their priority population is easier to To identify so something like people over 65, where you really just looking at driver's license is or other documentation to show that they qualify. You cannot just do that, though, And this is the important part. I want emphasize you need to pair that with an effort to make sure you're reaching vulnerable populations, so thank essential workers and meat packing facilities. Or, uh, vulnerable populations with high health risk federal federally qualified health centers. And to do that you also need to pair what you're doing on the mass vaccination side with mobile clinic second reach those more vulnerable populations. How do you get the messaging to be single and national lead? I mean, we're hearing you know the face masking messaging, the keeping kids home from school or or not messaging. Is there any way to nationalize that, or is that not a good idea?.

Coming up next